## Abstract Rippling muscle disease (RMD) is a benign myopathy with symptoms and signs of muscular hyperirritability. We report a 17‐year‐old patient who presented with muscular hypertrophy, local mounding on percussion, and a rippling phenomenon. Needle electromyography showed electrical silence d
Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease
✍ Scribed by Christian Kubisch; Benedikt G. H. Schoser; Monika v. Düring; Regina C. Betz; Hans-Hilmar Goebel; Susanne Zahn; Antje Ehrbrecht; Jan Aasly; Anja Schroers; Nikola Popovic; Hanns Lochmüller; J. Michael Schröder; Thomas Brüning; Jean-Pierre Malin; Britta Fricke; Hans-Michael Meinck; Torberg Torbergsen; Hartmut Engels; Bruno Voss; Matthias Vorgerd
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 702 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Thirty‐nine members, ages 1 to 67 years, of a Swedish family with rippling muscle disease (RMD) were investigated to assess genotype–phenotype correlations. Clinical, neurophysiological, and muscle morphological examinations were performed. Genetic analysis was performed in 38 individua
Cardiac sodium channels are key players in the generation and propagation of action potentials in the human heart. Heterozygous mutations in the SCN5A gene have been found to be associated with long QT syndrome, Brugada syndrome, and sinus node dysfunction (SND). Recently, overlapping arrhythmia phe
We report the clinical features of 21 unrelated cystic fibrosis (CF) patients from Portugal and Spain, who carry the mutation R1066C in the CFTR gene. The current age of the patients was higher in the R1066C/any mutation group (P < 0.01), as compared to the aF508/aF508 group. Poor values for lung ra
Several different mutations in the glycogen-debranching enzyme gene AGL have been found in patients with glycogen storage disease type III (GSD III) to date, but no missense mutations have been reported for GSD III, only nonsense, splicing, and deletion/insertion lesions. Here we describe a novel G1